Cleared Special

K201464 - Altapore MIS

K201464 is the FDA 510(k) clearance for Altapore MIS by Baxter Healthcare Corporation. It is a Class 2 Orthopedic device (product code MQV) cleared through the Special 510(k) pathway after a 28-day FDA review.

K201464 · Baxter Healthcare Corporation · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
28d
Days
Class 2
Risk

K201464 is an FDA 510(k) clearance for the Altapore MIS. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Baxter Healthcare Corporation (Round Lake, US). The FDA issued a Cleared decision on June 30, 2020 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Baxter Healthcare Corporation devices

Submission Details

510(k) Number K201464 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2020
Decision Date June 30, 2020
Days to Decision 28 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 122d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 232
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K201464.
Cerament Bone Void Filler
K201535 · Bonesupport AB · Oct 2020
OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft
K200064 · SurGenTec, LLC · Aug 2020
CureOs TCP
K191670 · Linacol Muh Dan Kim Cev Tek Med Ith Ihr San VE Tic · Aug 2020
SIGNAFUSE Bioactive Bone Graft
K193513 · Bioventus · Jun 2020
Osteo3 ZP Putty
K193075 · Sirakoss , Ltd. · Jun 2020
Resorbable Mesh Pouch (Ballast MT, OsteoBallast MT)
K200290 · SeaSpine Orthopedics Corporation · May 2020